| Date | Title | Description | Source |
| 25.04.2024 | Interim report Q1/2024: MDR certification opens up great com... | Interim report Q1/2024: MDR certification opens up great commercial opportunities
Thu, Apr 25, 2024 ... | news.cisio... |
| 09.04.2024 | Enzymatica publishes annual report for 2023 | Enzymatica publishes annual report for 2023
Tue, Apr 09, 2024 08:30 CET Report this content
The annu... | news.cisio... |
| 27.03.2024 | Notice of Annual General Meeting 2024 in Enzymatica AB (publ... | Notice of Annual General Meeting 2024 in Enzymatica AB (publ)
Wed, Mar 27, 2024 19:45 CET Report thi... | news.cisio... |
| 19.02.2024 | Enzymatica publishes information memorandum about rights iss... | Enzymatica publishes information memorandum about rights issue of shares
Mon, Feb 19, 2024 16:00 CET... | news.cisio... |
| 16.02.2024 | Year-end report 2023: Scientific and regulatory progress gen... | Year-end report 2023: Scientific and regulatory progress generating international interest
Fri, Feb ... | news.cisio... |
| 07.11.2023 | Interim report Q3/2023: Research results that reshape the co... | Interim report Q3/2023: Research results that reshape the competitive landscape
Tue, Nov 07, 2023 08... | news.cisio... |
| 18.07.2023 | Interim report Q2/2023: An exciting and important time ahead | Interim report Q2/2023: An exciting and important time ahead
Tue, Jul 18, 2023 08:30 CET Report this... | news.cisio... |
| 04.05.2023 | Bulletin from Annual General Meeting of Enzymatica AB (publ) | Bulletin from Annual General Meeting of Enzymatica AB (publ)
Thu, May 04, 2023 16:00 CET Report this... | news.cisio... |
| 27.04.2023 | Interim report Q1/2023: Strong start to the year – Enzymatic... | Interim report Q1/2023: Strong start to the year – Enzymatica’s growth journey continues according t... | news.cisio... |
| 31.03.2023 | Notice of Annual General Meeting 2023 in Enzymatica AB (publ... | Notice of Annual General Meeting 2023 in Enzymatica AB (publ)
Fri, Mar 31, 2023 13:40 CET Report thi... | news.cisio... |
| 17.02.2023 | Interim report Q4/2022: A year that laid the foundation for ... | Interim report Q4/2022: A year that laid the foundation for growth
Fri, Feb 17, 2023 08:30 CET Repor... | news.cisio... |
| 02.11.2022 | Interim report Q3/2022: A broader role for ColdZyme adds pot... | Interim report Q3/2022: A broader role for ColdZyme adds potential for the future
Wed, Nov 02, 2022 ... | news.cisio... |
| 19.07.2022 | Interim report Q2/2022: Improved sales give confidence for t... | Interim report Q2/2022: Improved sales give confidence for the future
Tue, Jul 19, 2022 08:30 CET Re... | news.cisio... |
| 28.04.2022 | Interim report Q1/2022: Our financial targets remain in plac... | Interim report Q1/2022: Our financial targets remain in place
Thu, Apr 28, 2022 08:30 CET Report thi... | news.cisio... |
| 17.02.2022 | Year-end report: Clear signs of favourable market trends aft... | Year-end report: Clear signs of favourable market trends after a challenging 2021
Thu, Feb 17, 2022 ... | news.cisio... |
| 12.01.2022 | Enzymatica comments on wrongful wording in Dagens Medicin | Enzymatica comments on wrongful wording in Dagens Medicin Wed, Jan 12, 2022 14:35 CET
The headline a... | news.cisio... |
| 02.11.2021 | The long-term plan remains in challenging times | The long-term plan remains in challenging times Tue, Nov 02, 2021 08:50 CET
INTERIM REPORT JANUARY-S... | news.cisio... |
| 02.11.2021 | Interim Report Q3 | Interim Report Q3
January-September 2021
Enzymatica AB is a life science company that develops and s... | marketscre... |
| 29.09.2021 | Notice of extraordinary general meeting in Enzymatica AB (pu... | Notice of extraordinary general meeting in Enzymatica AB (publ) Wed, Sep 29, 2021 16:50 CET
The shar... | news.cisio... |
| 08.09.2021 | Claus Egstrand takes office as CEO ahead of schedule | Claus Egstrand takes office as CEO ahead of schedule Wed, Sep 08, 2021 11:00 CET
Claus Egstrand assu... | news.cisio... |
| 11.08.2021 | Chinese and US patent authorities issue notices of allowance... | Chinese and US patent authorities issue notices of allowance for patent for key component in cold sp... | news.cisio... |
| 16.07.2021 | Enzymatica : Interim Report January - June 2021 | INTERIM REPORT FOR
ENZYMATICA AB (PUBL)
JANUARY-JUNE 2021
Continued lower sales due to pandemic but ... | marketscre... |
| 16.07.2021 | Continued lower sales due to pandemic but some stabilization | Continued lower sales due to pandemic but some stabilization Fri, Jul 16, 2021 08:30 CET
Q2 Net sale... | news.cisio... |
| 12.07.2021 | Enzymatica and STADA extend agreement on ViruProtect to Viet... | Enzymatica and STADA extend agreement on ViruProtect to Vietnam Mon, Jul 12, 2021 15:00 CET
Enzymati... | news.cisio... |
| 07.06.2021 | Enzymatica announces outcome of new rights issue | Enzymatica announces outcome of new rights issue Mon, Jun 07, 2021 17:08 CET
NOT FOR RELEASE, PUBLIC... | news.cisio... |
| 03.06.2021 | Enzymatica launches ColdZyme on Amazon | Enzymatica launches ColdZyme on Amazon Thu, Jun 03, 2021 14:45 CET
Enzymatica now launches its commo... | news.cisio... |
| 21.05.2021 | Patent for ColdZyme approved in Japan | Patent for ColdZyme approved in Japan Fri, May 21, 2021 08:30 CET
The Japanese patent authority has ... | news.cisio... |
| 31.03.2021 | ENZYMATICA AB
Enzymatica : Publication of the Annual Report... | Enzymatica announces today that the annual report 2020 is available on the company's web site www.en... | marketscre... |
| 31.03.2021 | Enzymatica Publication of the Annual Report 2020 | Enzymatica Publication of the Annual Report 2020 Wed, Mar 31, 2021 09:00 CET
Enzymatica announces to... | news.cisio... |
